A new study published in Urologic Oncology: Seminars and Original Investigations sheds light on the natural history and outcomes of urothelial carcinoma of the bladder (UCB) with isolated lymph node metastasis after surgical resection. While patients with UCB and pathologic lymph node involvement have a poor prognosis, some patients have experienced durable survival following surgical resection. To date, data that describe the natural history of UCB in patients with isolated lymph node involvement (cN0pN+) following radical cystectomy with pelvic lymph node dissection are ...
Advertisement
Advertisement
Latest News
DLRS-based MLP was clinical useful in distinguishing non-muscle-invasive bladder cancer from muscle-invasive bladder cancer.
For patients with mRCC, durable complete response to sunitinib can be achieved irrespective of prognostic group...
Patients with mccRCC and high body mass index may experience better outcomes when treated with immune checkpoint blockades.
18F-sodium fluoride positron emission tomography-computed tomography may better detect skeletal metastases in patients
Further study is needed to determine if certain biomarkers can aid in determining effectiveness and safety.
Increasing BMI in prostate cancer was associated with Gleason Grade Group 3 and pT3 stage PZ tumors and larger TZ tumors.
Advertisement
Advertisement
Editorial Advisory Board
Catherine H. Marshall, MD, MPHEditor | Assistant Professor of Oncology at the Johns Hopkins University School of Medicine
Jérémie Calais, MD, MScEditor | Director of the Theranostics and Clinical Research Programs at the University of California, Los Angeles
Akhil Abraham Saji, MDAssociate Editor | Urology Resident at New York Medical College/Westchester Medical Center
David Ambinder, MDAssociate Editor | Urology Resident at New York Medical College/Westchester Medical Center
Knowledge Hubs
Curated clinical content based on conditions, therapies, and technologies
GU Oncology Now delivers the latest news in clinical trials, conference coverage, and more, highlighting advancements in genitourinary oncology treatments and tech.
Get research and breaking news straight to your inbox.
Conference Coverage
Live meeting highlights
A new study has found an association between neurodevelopmental disorders and testicular seminoma.
CLEAR study results showed that treatment with first-line lenvatinib plus pembrolizumab had clinical benefit at 2 years.
The RACE IT trial finds neoadjuvant radio-immunotherapy followed by radical cystectomy a safe and feasible treatment option.
Patients with mCRPC with AR alterations had significantly worse survival outcomes compared with patients with wild-type.
The Uromigos
Podcasts hosted by Professors Thomas Powles, MD, and Brian Rini, MD
Expert Interviews
Clinical discussions with experts in the field
Journal
Articles from the GU Oncology Now Journal
Up to one-third of all UTUC patients present with variant histology, such as squamous or micropapillary features.
Stereotactic body radiotherapy can benefit RCC patients deemed unfit for surgical therapy.
1 of 4 will UTUC patients will have a variant histologic subtype such as squamous cell, micropapillary, or neuroendocrine.
The multicenter phase 3 randomized controlled PHOTO trial examined if blue light cystoscopy could improve patient outcomes.
Robert Uzzo gives an overview of the RENAL score that he developed, plus his outlook on the future of renal characterization.
The history of robot-assisted laparoscopic & open radical prostatectomies are discussed with their outcomes and future uses.
